110 related articles for article (PubMed ID: 15744091)
1. Pharmacokinetic behavior of micafungin in rats with carbon tetrachloride-induced acute hepatic failure.
Konishi H; Sudo M; Sumi M; Morii H; Minouchi T; Aimoto T; Yamaji A
Biol Pharm Bull; 2005 Mar; 28(3):556-9. PubMed ID: 15744091
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats.
Niwa T; Yokota Y; Tokunaga A; Yamato Y; Kagayama A; Fujiwara T; Hatakeyama J; Anezaki M; Ohtsuka Y; Takagi A
Biol Pharm Bull; 2004 Jul; 27(7):1154-6. PubMed ID: 15256761
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction.
Hebert MF; Smith HE; Marbury TC; Swan SK; Smith WB; Townsend RW; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Oct; 45(10):1145-52. PubMed ID: 16172179
[TBL] [Abstract][Full Text] [Related]
4. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.
Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL
Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155
[TBL] [Abstract][Full Text] [Related]
6. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
[TBL] [Abstract][Full Text] [Related]
8. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections.
Tabata K; Katashima M; Kawamura A; Kaibara A; Tanigawara Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):324-31. PubMed ID: 16946560
[TBL] [Abstract][Full Text] [Related]
10. Effect of blood decrease on micafungin disposition in rats.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the blood level of micafungin involving patients with hematological diseases: new findings regarding combination therapy with tacrolimus.
Shimoeda S; Ohta S; Kobayashi H; Saitou H; Kubota A; Yamato S; Shimada K; Sasaki M; Kawano K
Biol Pharm Bull; 2005 Mar; 28(3):477-80. PubMed ID: 15744072
[TBL] [Abstract][Full Text] [Related]
12. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
13. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.
Seibel NL; Schwartz C; Arrieta A; Flynn P; Shad A; Albano E; Keirns J; Lau WM; Facklam DP; Buell DN; Walsh TJ
Antimicrob Agents Chemother; 2005 Aug; 49(8):3317-24. PubMed ID: 16048942
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of antifungal agent micafungin in critically ill patients receiving continuous hemodialysis filtration.
Hirata K; Aoyama T; Matsumoto Y; Ogawa F; Yamazaki H; Kikuti A; Yamamoto Y
Yakugaku Zasshi; 2007 May; 127(5):897-901. PubMed ID: 17473532
[TBL] [Abstract][Full Text] [Related]
15. Optimal prophylactic dosage and disposition of micafungin in living donor liver recipients.
Kishino S; Ohno K; Shimamura T; Furukawatodo H
Clin Transplant; 2004 Dec; 18(6):676-80. PubMed ID: 15516243
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis.
Tabata K; Katashima M; Kawamura A; Kagayama A; Kohno S
Eur J Drug Metab Pharmacokinet; 2006; 31(2):123-8. PubMed ID: 16898081
[TBL] [Abstract][Full Text] [Related]
17. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
18. Role of plasma proteins in pharmacokinetics of micafungin, an antifungal antibiotic, in analbuminemic rats.
Abe F; Ueyama J; Kawasumi N; Nadai M; Hayashi T; Kato M; Ohnishi M; Saito H; Takeyama N; Hasegawa T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3454-6. PubMed ID: 18591270
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
Hiemenz J; Cagnoni P; Simpson D; Devine S; Chao N; Keirns J; Lau W; Facklam D; Buell D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1331-6. PubMed ID: 15793107
[TBL] [Abstract][Full Text] [Related]
20. Effects of hepatic CYP3A4 activity on disposition of micafungin in liver transplant recipients with markedly small-for-size grafts.
Mochizuki N; Matsumoto K; Ohno K; Shimamura T; Furukawa H; Todo S; Kishino S
Transplant Proc; 2006 Dec; 38(10):3649-50. PubMed ID: 17175357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
